SCHEMBL18009305

SCHEMBL18009305

CCOCCN(CCOCC)C(=O)[C@@H]1C[C@@H](OC(=O)/C=C/C(=O)OC)CN1C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009299 0.91 PIK3CD (0.30) —
SCHEMBL18009223 0.87 PIK3CD (0.32) —
SCHEMBL18009358 0.87 PIK3CD (0.32) —
SCHEMBL18007455 0.82 NAMPT (0.35) —
SCHEMBL18009295 0.82 PIK3CD (0.34) —
SCHEMBL18009388 0.80 PEPD (0.34) —
SCHEMBL18007459 0.80 MMP2 (0.34) —
SCHEMBL18009192 0.78 PIK3CD (0.36) —
SCHEMBL18009194 0.78 PEPD (0.39) —
SCHEMBL18009464 0.77 MMP2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback